MOG1 Rescues Defective Trafficking of Na v 1.5 Mutations in Brugada Syndrome and Sick Sinus Syndrome
- 1 April 2013
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Arrhythmia and Electrophysiology
- Vol. 6 (2), 392-401
- https://doi.org/10.1161/circep.111.000206
Abstract
Background—: Loss-of-function mutations in Na v 1.5 cause sodium channelopathies, including Brugada syndrome, dilated cardiomyopathy, and sick sinus syndrome; however, no effective therapy exists. MOG1 increases plasma membrane (PM) expression of Na v 1.5 and sodium current ( I Na ) density, thus we hypothesize that MOG1 can serve as a therapeutic target for sodium channelopathies. Methods and Results—: Knockdown of MOG1 expression using small interfering RNAs reduced Na v 1.5 PM expression, decreased I Na densities by 2-fold in HEK/Na v 1.5 cells and nearly abolished I Na in mouse cardiomyocytes. MOG1 did not affect Na v 1.5 PM turnover. MOG 1 small interfering RNAs caused retention of Na v 1.5 in endoplasmic reticulum, disrupted the distribution of Na v 1.5 into caveolin-3–enriched microdomains, and led to redistribution of Na v 1.5 to noncaveolin-rich domains. MOG1 fully rescued the reduced PM expression and I Na densities by Na v 1.5 trafficking–defective mutation D1275N associated with sick sinus syndrome/dilated cardiomyopathy/atrial arrhythmias. For Brugada syndrome mutation G1743R, MOG1 restored the impaired PM expression of the mutant protein and restored I Na in a heterozygous state (mixture of wild type and mutant Na v 1.5) to a full level of a homozygous wild-type state. Conclusions—: Use of MOG1 to enhance Na v 1.5 trafficking to PM may be a potential personalized therapeutic approach for some patients with Brugada syndrome, dilated cardiomyopathy, and sick sinus syndrome in the future.Keywords
This publication has 14 references indexed in Scilit:
- Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmiaProceedings of the National Academy of Sciences of the United States of America, 2012
- Striking In Vivo Phenotype of a Disease-Associated Human SCN5A Mutation Producing Minimal Changes in VitroCirculation, 2011
- MOG1Circulation: Cardiovascular Genetics, 2011
- Multiple Loss-of-Function Mechanisms Contribute to SCN5A-Related Familial Sick Sinus SyndromePLOS ONE, 2010
- SCN5A channelopathies – An update on mutations and mechanismsProgress in Biophysics and Molecular Biology, 2008
- HEK293 cell line: A vehicle for the expression of recombinant proteinsJournal of Pharmacological and Toxicological Methods, 2005
- Rab13 Mediates the Continuous Endocytic Recycling of Occludin to the Cell SurfaceOnline Journal of Public Health Informatics, 2005
- A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugsCardiovascular Research, 2004
- Localization of Cardiac Sodium Channels in Caveolin-Rich Membrane DomainsCirculation Research, 2002
- Multiple Mechanisms of Na + Channel– Linked Long-QT SyndromeCirculation Research, 1996